News summary:

• Silo Communications needed a scalable fiber access platform to bring faster, more reliable broadband to underserved communities
• With Adtran’s technology and intelligent software, Silo Communications is strengthening service delivery as it evolves from wireless to fiber
• Deployment supports wider state and federal efforts to close the digital divide and create a foundation for long-term rural growth

WINNEBAGO, Ill.–(BUSINESS WIRE)– Adtran today announced that Silo Communications, a rural broadband provider based in northern Illinois, is using its fiber access portfolio and software applications to expand high-speed connectivity for underserved homes and businesses. As demand for reliable broadband continues to grow across communities, Silo Communications is building on its wireless heritage with a scalable fiber network designed to support higher speeds, stronger service reliability and future expansion. The deployment supports wider state and federal efforts to extend high-speed connectivity to underserved rural areas, strengthening Silo Communications’ ability to connect residents, local enterprises and agricultural businesses that have historically had limited access to high-performance broadband.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716640241/en/

Adtran’s fiber access technology is helping Silo Communications deliver high-speed connectivity to underserved communities across northern Illinois.

“Silo Communications was built out of a need we saw every day in our own rural communities. Farms, homes and businesses needed better internet, and we knew there had to be a practical way to deliver it,” said Luke Grocholl, founder and president of Silo Communications. “What started as a local effort to connect nearby customers has grown into a wider network serving locations across northern Illinois. Adtran has been a close and responsive partner throughout that growth, giving us the technology, guidance and flexibility to expand our services with confidence. Together, we’re building a stronger network focused on dependable connectivity, long-term value and the needs of the people and places we serve.”

Silo Communications is deploying Adtran’s SDX fiber access platform to support high-performance connectivity from access infrastructure into homes and businesses. The network is managed through Adtran’s Mosaic software suite, providing automation that helps streamline operations as the fiber footprint grows. Silo Communications is also using Adtran’s service delivery gateways powered by Intellifi® to deliver a more consistent and reliable in-home experience, with support for multigigabit Wi‑Fi delivery, alongside remote visibility that improves customer support. Together, these technologies provide a scalable foundation that enhances subscriber experiences and enables more agile network expansion across rural areas.

“Silo Communications is a great example of the new generation of locally focused providers transforming broadband access in rural America,” commented Jeremy Harris, VP of North America sales at Adtran. “Their team is entrepreneurial, ambitious and deeply connected to the people they serve, with a clear focus on solving real connectivity challenges. By combining scalable fiber access technology with intelligent software, we’re helping Silo Communications expand efficiently, improve operational insight and deliver reliable broadband where it matters most. This project reflects the momentum we’re seeing across rural markets as dynamic providers build networks that support digital inclusion, economic opportunity and long-term community resilience.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the majority shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by

ADTRAN Holdings, Inc.

www.adtran.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260716640241/en/

Contacts

For media
Gareth Spence

+44 1904 699 358

public.relations@adtran.com

For investors
Rob Fink

+1 646 809 4048

investor.relations@adtran.com

LONDON–(BUSINESS WIRE)– To successfully embrace the power of AI, businesses need to remove organizational complexity and eliminate unnecessary work, rather than simply using it for fragmented, incremental improvements. Boards must act now to deliver this. That is the key message from AI-First or Disrupted: Beating the Nightmare Competitor, a new report from Arthur D. Little (ADL) based on concrete examples from leading organizations.

Within three to five years, AI-first competitors will make faster decisions, have flatter organizations, and operate at lower costs. They will not just optimize handovers between teams, approvals, and reconciliation work; they will eliminate these complex processes entirely.

AI is completely changing the economics of work and value creation, removing the need for coordination across multiple teams, while also enabling adaptive, predictive, and personalized products and services. This delivers both lower operational costs and a fundamentally stronger value proposition.

However, most organizations are simply deploying AI inside existing complexity instead of removing it, delivering incremental gains but failing to provide structural advantage. Essentially the organization’s “immune system” protects existing roles and ways of working, holding back the potential for transformation.

The report therefore outlines that the main barrier to achieving AI advantage is organizational, not technological. Creating real impact requires boards to drive structural change and alignment across Arthur D. Little’s (ADL’s) strategy, processes, resources, organization, and culture (SPROC) framework.

Johan Treutiger, Partner, Arthur D. Little, comments: “Your nightmare competitor is not bigger or better funded. It’s AI-first, radically simpler, and has eliminated work you still manage. To survive, boards must ensure that their strategy, processes, resources, organization, and culture are aligned, otherwise the benefits of AI will remain incremental, leaving organizations at the mercy of AI-first nightmare competitors.”

Petter Kilefors, Partner, Arthur D. Little, comments: “The real AI divide is not between adopters and non-adopters, but between those who optimize work and those who eliminate it. For boards, the implication is clear: AI has moved from an innovation topic to a competitiveness ideal. They must define where AI will change the economics of the business within three to five years and ensure execution through redesign, governance, and incentives that reward simplification over complexity.“

Report download: www.adlittle.com/en/ai-first-or-disrupted-beating-nightmare-competitor

For further information, please visit www.adlittle.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260617728441/en/

Contacts

Media Contact:

Sue Glanville

Catalyst Comms

+44 7715 817589

Glanville.Sue@adlittle.com

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023

PARIS & LONDON–(BUSINESS WIRE)– Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment.

The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, development and commercialization.

The collaboration now runs across continents, between Aqemia researchers in Paris and London and Sanofi researchers in Boston, Frankfurt and Paris. Aqemia’s platform has been put to work on Sanofi’s targets of interest, including difficult, first-in-class projects with limited chemical data upfront, and the joint way of working is now well established.

Sanofi is now taking a step further by nominating a new therapeutic target, expanding the scope of the work and triggering a milestone payment. The nomination reflects the confidence both teams place in the platform and in the people to address a growing range of research projects.

Maximilien Levesque, CEO and co-founder of Aqemia, commented, “We are thrilled to expand the collaboration with the nomination of a new target. It shows that our physics-based generative AI can deliver on real, hard projects, and reflects the strong ways of working and trust between our teams. We are committed to inventing innovative drugs in close alliance with Sanofi’s experts.”

About Aqemia

Aqemia is the drug invention company combining generative AI and quantum-inspired physics to invent novel small molecule drugs that address unmet medical needs. Powered by Qemi, its proprietary physics-based generative AI platform, Aqemia designs novel drug candidates in a repeatable, frugal and scalable way. Unlike approaches that require large amounts of experimental data to train on, Aqemia generates the data it needs in-house through highly efficient physics-based calculations, right from the start of each research project. Founded in 2019 and based in Paris, France, and London, UK, Aqemia partners with leading pharmaceutical companies and builds its own pipeline across critical diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260717090949/en/

Contacts

contact@aqemia.com

BUENOS AIRES, Argentina–(BUSINESS WIRE)– Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country’s national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/

By connecting to Argentina’s national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide.

This service helps to enhance global travellers’ travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina, similar to when they make digital payments in their home countries.

Alipay+ now connects 150 million merchants to over 50 global digital wallets and banking apps, reaching 2 billion user accounts. The merchant network includes those connected through over 10 national QR schemes across Asia and Middle East. Alipay+ partner apps will be enabled for cross-border payments in Argentina in phases. This would help local merchants, especially small businesses, to serve more international customers while continuing to use their existing QR acceptance infrastructure.

Argentina is home to one of the world’s most advanced mobile payment ecosystems, where QR code payments is an integral part of everyday commerce. At its core is Transferencias 3.0, the national interoperable instant payment infrastructure developed by the Central Bank of the Argentine Republic (BCRA), which enables consumers to pay with any participating digital wallet or banking app by scanning a single QR code.

“The way people pay is changing rapidly, and merchants need payment experiences that evolve at the same pace,” said Lucio Colunga, CEO of PVS. “Through our partnership with Alipay+, we are giving merchants across Latin America access to one of the world’s largest digital payment ecosystems, connecting them with more than 2 billion user accounts worldwide. This enables international travellers to pay with the wallets they already know and trust while creating new growth opportunities for businesses across the region. This is another step toward a more connected, interoperable and global payments ecosystem.”

“Argentina’s highly interoperable digital payment ecosystem creates a strong foundation for seamless digital commerce,” said Weixiao Jiang, General Manager for North Asia and the Americas, Alipay+, Ant International. “We’re honoured to integrate with the national QR payment scheme through the partnership with PVS. By connecting travellers from key international markets with a broad network of merchants, we hope to help boost inbound visitor spending, supporting the country’s tourism economy while bringing more opportunities for local businesses.”

With an average of over 20 million daily transactions, Ant International is a leading global digital payment, digitisation and financial technology provider. It supports financial institutions and merchants of all sizes across Asia, Europe, and the Americas with a comprehensive suite of solutions, ranging from payment and account services to embedded credit services, treasury management and other AI-powered financial innovations.

This latest initiative follows Alipay+’s partnership with PVS in May 2026 to roll out cross-border mobile payment service in Argentina and Chile. In addition, Ant International became the Argentina National Football Team’s official sponsor for the Asia region (excluding the Middle East) in March 2026.

Beyond Argentina, Ant International is expanding partnerships with global and local payment service providers, fintech companies and digital platforms to broaden access to cross-border payments and inclusive financial services for businesses and consumers across Latin America. Recent initiatives include the co-launch of a digital wallet and the advancement of digital payments in Mexico, as well as expanding access to financing for underserved SMEs and individuals in Brazil.

Alongside QR code payment, Alipay+ NFC (near-field communication) enables cross-border transactions through its partnership with Mastercard. Starting with AlipayHK, GCash and Kakao Pay, users can now make NFC payments at Mastercard-enabled merchants worldwide, including across Argentina, Brazil, Mexico and other Latin American markets.

About Alipay+

Ant International’s Alipay+ is a unified wallet gateway with cross-border payment and digitisation services that help connect global merchants to consumers. Consumers enjoy seamless payments a broad choice of deals and the convenience of digital services using their preferred payment app/e-wallet while travelling abroad. Many small and medium-sized businesses already use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260717276406/en/

Contacts

Ant International

PR@ant-intl.com

• Accelerates AI‑driven transformation through expanded agentic AI and data engineering capabilities that underpin NTT DATA’s AI strategy
• Adds 1,000 Azure engineers and AI specialists to scale cloud and AI delivery capabilities
• Advances NTT DATA’s North America leadership position, scaling industry aligned AI led innovation across its cloud services and Microsoft Business Unit
• Builds on NTT DATA’s position as the fastest-growing Microsoft GSI partner, accelerating co-innovation in enterprise AI

PLANO, Texas–(BUSINESS WIRE)– NTT DATA, a global leader in AI, digital business and IT services, today announced it has signed a definitive agreement to acquire WinWire, an award-winning Microsoft partner specializing in Agentic AI, AI on Azure, data engineering and cloud-native development as foundational capabilities for enterprise AI. The acquisition strengthens NTT DATA’s position as a trusted partner to help organizations move beyond experimentation to operationalize AI at scale.

The acquisition further advances NTT DATA’s enterprise AI strategy as demand accelerates for AI-driven, cloud-native transformation. By expanding capabilities across data platforms, agentic AI and modern applications, NTT DATA is sharpening its ability to deliver production-ready AI solutions aligned to industry needs, reinforcing its leadership as Microsoft’s Global System Integrator (GSI) Growth Champion Partner of the Year.

Upon closing, WinWire will add more than 1,000 skilled Azure engineers and Microsoft specialists to NTT DATA, bringing deep experience across Microsoft environments, including Microsoft Fabric and Azure AI Foundry. This expanded talent base will strengthen NTT DATA’s global Microsoft practice and accelerate the delivery of next‑generation AI and cloud solutions.

These expanded capabilities, combined with WinWire’s proven industry specialization and long‑standing partnership with Microsoft, will enhance NTT DATA’s ability to deliver industry‑specific, cloud‑native and agentic AI solutions that address complex business challenges securely and consistently.

As enterprises increasingly demand AI platforms that support enterprise-wide transformation, industry analysts estimate the global AI market will grow from $390 billion to nearly $3.5 trillion over the next decade, highlighting the scale of AI adoption across enterprises.

By combining NTT DATA’s full-stack capabilities, industry expertise and managed services with WinWire’s specialized strengths in modern applications, data engineering and agentic AI, the company is uniquely positioned to help clients develop and scale AI solutions and unlock value from AI across the enterprise.

Headquartered in Santa Clara, California, with global delivery centers in India, WinWire is a trusted Microsoft partner and a six‑time Microsoft Partner of the Year Award winner and finalist, supporting enterprises in establishing AI‑ready digital foundations and scaling intelligent, cloud‑based solutions that deliver measurable business outcomes.

“The acquisition of WinWire is a decisive step in advancing our enterprise AI strategy and expanding our leadership in Microsoft Azure and AI-powered cloud transformation,” said Abhijit Dubey, CEO and Chief AI Officer, NTT DATA, Inc. “By combining WinWire’s deep expertise in cloud-native development and agentic AI with NTT DATA’s global scale, this positions us to lead the shift to enterprise AI, enabling clients to move from experimentation to enterprise-wide deployment and achieve meaningful business outcomes.”

Building on NTT DATA’s strategic partnership with Microsoft

The agreement builds on NTT DATA’s long-standing strategic partnership with Microsoft, combining its global scale with WinWire’s award-winning expertise in Azure-based AI and data transformation.

WinWire is also a member of the Microsoft Agentic Partner Alliance Program, further strengthening joint innovation and execution for industry-specific AI solutions.

WinWire will complement NTT DATA’s Global Business Unit for Microsoft Cloud, established to meet rising demand for secure, AI-driven enterprise transformation. The business unit spans Microsoft Cloud, security and AI, supported by more than 24,000 Microsoft certifications and operates across more than 50 countries.

The combined capabilities also reinforce NTT DATA’s ability to co-innovate and co-sell with Microsoft, building on its recognition as Microsoft’s 2025 Global System Integrator Growth Champion partner of the year.

“As a leading Microsoft Solutions Partner recognized through multiple awards over the years, we built WinWire with a clear focus on delivering meaningful Microsoft Azure and AI-led transformation for our enterprise clients,” said Ashu Goel, CEO, WinWire. “Joining NTT DATA marks an exciting new chapter, allowing us to extend our capabilities to a much broader global client base. Together, we are well positioned to accelerate innovation and shape the next wave of AI-driven transformation for our clients.”

“As enterprises look to unlock the full value of AI on Microsoft Azure, the role of skilled partners has never been more critical,” said Stephen Boyle, CVP, Enterprise Partner Solutions Microsoft. “By combining NTT DATA’s global scale with WinWire’s expertise in cloud-native development and agentic AI, this acquisition enhances our joint ability to co-innovate and deliver transformative solutions.”

Advancing client outcomes through cloud-native and AI-driven transformation

WinWire brings differentiated agentic AI, including its Agentic AI @ Scale framework, enabling the design and deployment of intelligent, autonomous systems embedded directly into enterprise workflows. Its portfolio of AI frameworks and industry accelerators helps organizations move from pilot initiatives to enterprise-scale AI adoption.

The combined portfolio spanning infrastructure, applications, data, AI and managed services will enable faster time to value and secure enterprise-scale AI deployment.

The transaction is subject to customary closing conditions and regulatory approvals. Rothschild & Co acted as the exclusive financial advisor to NTT DATA on the transaction.

About NTT DATA

NTT DATA is a $30+ billion business and technology services leader, serving 75% of the Fortune Global 100. We are committed to accelerating client success and positively impacting society through responsible innovation. We are one of the world’s leading AI and digital infrastructure providers, with unmatched capabilities in enterprise-scale AI, cloud, security, connectivity, data centers and application services. Our consulting and industry solutions help organizations and society move confidently and sustainably into the digital future. As a Global Top Employer, we have experts in more than 70 countries. We also offer clients access to a robust ecosystem of innovation centers as well as established and start-up partners. NTT DATA is part of NTT Group, which invests over $3 billion each year in R&D. Visit us at nttdata.com.

About WinWire

WinWire unleashes the Power of Agentic AI to deliver innovative solutions that help our customers gain competitive advantage. WinWire is at the forefront of enabling enterprises in the Healthcare and Software and Digital Platforms (SDP) sectors to embark on a transformative Agentic AI journey.

As a globally recognized, multi-award-winning Agentic AI firm, WinWire delivers a spectrum of AI-led digital transformational services that include:

• Agentic AI Services – Harness the power of Agentic AI to accelerate the Frontier Firm Journey.
• Foundational AI Services – Data Estate & BI Modernization for AI-Ready data.
• Operational AI Services – Manage, optimize, and evolve agents and enterprise applications leveraging Agentic AI systems to reduce costs & enhance agility.
• Visit us at: https://www.winwire.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260515587720/en/

Contacts

Media Contacts

Lori Bosio | lori.bosio@nttdata.com

• Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring and support provided during treatment administration sessions were minimal, non-directive and distinct from conventional conceptions of psychotherapy

• Findings published in the Journal of Psychopharmacology

LONDON & NEW YORK–(BUSINESS WIRE)– Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a post-hoc analysis of support methods used in an open-label Phase 2 study of investigational COMP360 synthetic psilocybin treatment in patients with post-traumatic stress disorder (PTSD). Documented speech production between participants and support providers during treatment administration sessions showed minimal interaction. Monitoring and support were linked by patients to presence, availability, reassurance and validation. The limited and non-directive nature of these interactions distinguishes this form of support from therapeutic dialogues typically used in conventional psychotherapy or other trauma-focused psychological treatments.

“The monitoring and support we’ve incorporated across our COMP360 trials in both treatment-resistant depression and PTSD is designed to safeguard patients and protect data integrity during psychedelic treatment. Patients themselves have indicated they value a reassuring presence, but the key aspects of the experience are self-directed,” said Dr. Guy Goodwin, Chief Medical Officer of Compass Pathways. “These findings reinforce that the rapid and durable symptom improvement observed in the open-label Phase 2 PTSD trial was attributable to the psilocybin drug experience. It is incorrect to describe the treatment we are developing as psilocybin-assisted psychotherapy. We are happy to see these results published in the Journal of Psychopharmacology and excited to continue building upon the existing body of evidence supporting the transformative potential of COMP360 for the treatment of TRD and PTSD.”

Key Findings & Qualitative Themes

• The vast majority (78%) of the administration session was spent in silence.
• Support was minimal, yet relevant to patients’ feelings of safety and stability. Several participants described the support providers as a reliable and available resource if needed, but largely out of their awareness during treatment.
• Non-directive support strategies promoted autonomy through the introspective psychedelic state. Participants were empowered to sustain inward focus and self-navigate the treatment without the support provider leading, redirecting or reinterpreting the experience in any way.
• Primary modes of support included reassurance and validation from physical proximity.

These findings were published in the Journal of Psychopharmacology.

Compass Clinical Trial Monitoring & Support

Compass has developed a systematic training and mentoring program to ensure and measure quality and consistent monitoring and support for participants across all COMP360 trials in treatment-resistant depression (TRD) and PTSD. Support providers for trials are trained using a manualized approach based on historical clinical experience and regulatory guidance, reinforced with ongoing mentorship. Support strategies include breath and body awareness, short verbal cues, and physical proximity.

About Post-Traumatic Stress Disorder

Post-Traumatic Stress Disorder (PTSD) is a serious mental health condition that can develop after exposure to traumatic events such as personal assault, combat, natural disasters, or serious accidents. Characterized by symptoms such as intrusive memories, avoidance behaviors, negative shifts in mood and cognition, and heightened arousal, PTSD affects approximately five percent of adults in the U.S. annually. Symptoms may appear within months of the trauma or be delayed, and they must persist for over a month and interfere with daily functioning to meet diagnostic criteria.

PTSD can impact anyone, though certain populations—including veterans, first responders, and survivors of abuse—are at elevated risk. Individuals living with PTSD frequently experience comorbid mental health conditions, most commonly, depression, anxiety disorders, substance use disorders, as well as a significantly increased risk of suicide. These overlapping conditions can intensify distress and complicate treatment.

Affecting 13 million people in the U.S. each year, PTSD remains an underserved condition. There are currently only two FDA-approved medications for PTSD. This limited pharmacological landscape underscores the urgent need to advance care for patients experiencing this debilitating condition.

About Compass Pathways

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).

Compass is headquartered in London, UK, with offices in New York in the U.S. We envision a world where mental health means not just the absence of illness but the ability to thrive.

Forward-looking statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. In some cases, forward-looking statements can be identified by terminology such as “may”, “might”, “will”, “could”, “would”, “should”, “expect”, “intend”, “plan”, “objective”, “anticipate”, “believe”, “contemplate”, “estimate”, “predict”, “potential”, “continue” and “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements include express or implied statements relating to, among other things, statements regarding our business strategy and goals; the potential for our clinical trials to support regulatory filings and approvals; our expectations regarding the safety or efficacy of our investigational COMP360 psilocybin treatment, including as a treatment for treatment of TRD and PTSD; any implication that past results will be predictive of future results; our ability to obtain regulatory approval and adequate coverage and reimbursement; our ability to transition from a clinical-stage to a commercial-stage organization and effectively launch a commercial product, if regulatory approval is obtained; and our expectations regarding the benefits of our investigational COMP360 psilocybin treatment. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Compass’s control and which could cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements.

These risks, uncertainties, and other factors include, among others: uncertainties associated with risks related to clinical development which is a lengthy and expensive process with uncertain outcomes, and therefore our clinical trials may be delayed or terminated and may be more costly than expected; the results of early-stage clinical trials of our investigational COMP360 psilocybin treatment in PTSD may not be predictive of the results of our planned late-stage clinical trial in PTSD; our need for substantial additional funding to achieve our business goals and if we are unable to obtain this funding when needed and on acceptable terms, we could be forced to delay, limit or terminate our clinical trials; our efforts to obtain marketing approval from the applicable regulatory authorities in any jurisdiction for our investigational COMP360 psilocybin treatment may be unsuccessful; and our efforts to commercialize and obtain coverage and reimbursement for our investigational COMP360 psilocybin treatment, if approved, may be unsuccessful; and those risks and uncertainties described under the heading “Risk Factors” in Compass’s most recent annual report on Form 10-K or quarterly report on Form 10-Q, and in other reports we have filed with the U.S. Securities and Exchange Commission (“SEC”), which are available on the SEC’s website at www.sec.gov. Except as required by law, Compass disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Compass’s current expectations and speak only as of the date hereof.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260716248636/en/

Contacts

Enquiries
Media: Dana Sultan-Rothman, media@compasspathways.com
Investors: Stephen Schultz, stephen.schultz@compasspathways.com, +1 401 290 7324

The parties signed a ground lease agreement allowing installation of the optical ground station (OGS) at the NL Space Campus

LUXEMBOURG–(BUSINESS WIRE)– SES, a space solutions company, jointly with Airbus Netherlands B.V. signed a ground lease agreement with the Dutch municipality of Noordwijk for a plot at the NL Space Campus, next to the European Space Agency’s (ESA) technical center ESTeC. The facility will host a dedicated optical ground station (OGS) to communicate with the EAGLE-1 satellite and receive quantum safe keys via laser technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260714786947/en/

Breaking the ground of the EAGLE-1 Optical Ground Station, Municipality of Noordwijk, the Netherlands. Pictured left to right: Pim van Strien, Alderman for the Municipality of Noordwijk; Rob Postma, President and Managing Director, Airbus Netherlands; Alan Kuresevic, Managing Director, SES Techcom, SES.

The station, to be built by Airbus for SES, will consist of a control room, alongside a dome housing an ultra-precise telescope to track satellites, required for the laser link. To ensure the precision of the laser connection, the station will be equipped with advanced optics allowing it to correct real-time atmospheric distortions, such as turbulence caused by air movement or temperature fluctuations.

“The optical ground station will serve as the primary ground connection for the EAGLE-1 system managed by SES in a public-private partnership with ESA and the European Commission (EC). Once operational, the system will allow early adoption of the quantum-safe technology by users such as government and banking sector, enabling next-generation cybersecurity,” said Xavier Bertran, SES’ Chief Product and Innovation Officer.

Through the EAGLE-1 project, Europe will receive its first satellite to demonstrate end-to-end ultra-secure communication based on quantum technology. Comprising a satellite, a ground network, and advanced laser connection, EAGLE-1 is the first and major step in developing a European system for Quantum Key Distribution (QKD). Unlike traditional satellites using radio frequencies, the EAGLE-1 satellite link utilizes laser beams to transmit security keys, establishing an optimally secure connection over long distances.

Delivered by the prime contractor TNO, also responsible for advanced optics, the station’s technical implementation will leverage the expertise of other specialized partners, including FSO Instruments for delivering the sensor, Airbus Netherlands for the real-time control system, Officina Stellare for the telescope and dome, and Celestia STS, responsible for the optical digital modem.

Follow us on:

LinkedIn | Facebook | YouTube | Twitter | Instagram

Read our Blogs >

Visit the Media Gallery >

About SES

At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry leadership—backed by a track record of bringing innovation “firsts” to market. As a trusted partner to customers and the global space ecosystem, SES is driving impact that goes far beyond coverage. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com

About Airbus

Airbus pioneers sustainable aerospace for a safe and united world. The Company constantly innovates to provide efficient and technologically-advanced solutions in aerospace, defence, and connected services. In commercial aircraft, Airbus designs and manufactures modern and fuel-efficient airliners and associated services. Airbus is also a European leader in space systems, defence and security. In helicopters, Airbus provides efficient civil and military rotorcraft solutions and services worldwide.

Forward-looking Statements

This press release contains certain“forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “will”, “to be” and “enabling”.

Forward-looking statements are not assurances of future performance and are subject to inherent uncertainties and risks that are difficult to predict. Factors that might cause such a difference include those discussed in our filings with the US Securities and Exchange Commission, including our Form 20-F, such as risks relating to changes in technology or the satellite communications industry; risks relating to operations, systems, and ground infrastructure; and risks associated with strategic investments. The forward-looking statements included in this press release are made only as of the date hereof and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260714786947/en/

Contacts

For further information please contact:
SES Communications

SES.Press@ses.com

BEIJING–(BUSINESS WIRE)– Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend.

The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company previously extended that submission deadline to June 30, 2026, and has now further extended that submission deadline to December 31, 2026.

Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before December 31, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to undertake to receive the Dividend, please contact the Information Agent:

D.F. King & Co., Inc.

28 Liberty Street, 53rd Floor

New York, NY 10005

Attention: Sinovac Biotech Ltd. Special Dividend

Email: sva@dfking.com, with a subject line of Sinovac Biotech Ltd, Special Dividend

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive^®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu^®), the world’s first H1N1 influenza vaccine (Panflu.1^®), and CoronaVac^®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260710642585/en/

Contacts

Sinovac Biotech Ltd.
Helen Yang

Tel: +86-10-8279 9720

Email: ir@sinovac.com

Partnership combines the Databricks platform with West Monroe’s implementation expertise to help Clearlake build an “investment firm of the future” data platform across deal origination, due diligence, fund operations, and portfolio company transformation

SANTA MONICA, Calif.–(BUSINESS WIRE)– Clearlake Capital Group, L.P. (“Clearlake”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced a partnership with Databricks, the Data and AI company, and West Monroe, a global business and technology consulting firm, to accelerate Clearlake’s portfolio companies’ adoption of data, analytics, and AI capabilities.

Through the collaboration, Clearlake aims to connect investment, operational, financial, and portfolio data in a secure and scalable environment that accelerates enterprise-wide adoption of AI, drives productivity, and delivers measurable outcomes across the investment lifecycle from deal origination and due diligence to portfolio monitoring and value creation. By pairing cutting-edge technology with deep operational support, the partnership endeavors to help Clearlake’s portfolio companies stay ahead of industry disruption and build durable competitive advantage.

“Data and AI are increasingly becoming the core drivers of operational performance, better decision-making, and competitive advantage,” said Tony La Rosa, Managing Director, Technology and O.P.S.^® at Clearlake. “This partnership brings together the Databricks platform, West Monroe’s implementation expertise, and Clearlake’s O.P.S.^® (Operations, People, Strategy) framework to enhance our investment process leveraging AI technologies. The partnership also aims to help our portfolio companies accelerate growth by giving management teams access to modern data infrastructure and practical AI solutions needed to improve productivity, enhance customer engagement, and create durable long-term value.”

“Investment teams in private markets are sitting on a wealth of proprietary data across deal origination, due diligence, fund operations, and portfolio company transformation, but connecting that into a coherent advantage has always been the hard part,” said Andrea DeSosa, Global Head of Capital Markets GTM at Databricks. “By partnering with Databricks and West Monroe, Clearlake is creating a stronger foundation for teams to move faster and act with more confidence, turning proprietary data into context for better decisions with the governance and controls needed to scale AI across the firm.”

“The next generation of private equity value creation will be defined by firms that can connect investment thesis, diligence insights, operational data, and AI-enabled execution,” said Keith Campbell, Global Mergers & Acquisitions and Private Equity Lead at West Monroe, a Databricks Gold Partner that helps clients build modern lakehouse and AI-ready data platforms in just weeks. “Clearlake is positioning data as an operating capability, not just a technology asset, and that mindset can create meaningful advantages from deal origination through exit.”

As part of the initiative, Clearlake also plans to bring Databricks’ capabilities to portfolio companies through its Clearlake AI Labs initiative to help management teams modernize their data infrastructure, with a focus on identifying high-impact AI use cases, building scalable data foundations, and deploying solutions that support measurable business outcomes.

About Clearlake

Clearlake Capital is a leading global alternative asset manager founded in 2006 with over $185 billion of assets under management. Clearlake offers a broad range of investment solutions across private equity, credit, infrastructure, secondaries, co-investments, and other related private market strategies. Through Pathway Capital Management, a division of Clearlake, the firm serves institutional and wealth investors seeking diversified access to private markets. Clearlake seeks to partner with experienced management teams by providing patient, long-term capital to businesses across multiple sectors. The firm aims to drive value through its active, hands-on operating approach, O.P.S.^® (Operations, People, Strategy), which combines deep operational expertise with strategic and talent-focused initiatives. Headquartered in Santa Monica, Clearlake maintains 14 offices across the Americas, Europe, Asia, and the Middle East. For more information, please visit clearlake.com or follow us on LinkedIn.

About West Monroe

West Monroe is an AI-native global consulting firm built for today’s pace of change. We combine deep industry expertise with modern technology and business transformation capabilities to help organizations move faster, create value, and deliver measurable impact. We don’t just talk about what’s possible—we apply AI and technology where it matters most, pairing strategic insights with hands-on execution to help clients move from strategy to results, faster.

Clients tell us we show up differently. Our employee ownership model fuels an all-in approach grounded in practical execution, measurable impact, and lasting partnership. That commitment has earned recognition from Forbes and Business Insider and made West Monroe one of only 22 companies recognized worldwide for building high-quality careers. See what’s possible at westmonroe.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260714925130/en/

Contacts

Media Contacts:

For Clearlake
Tasha Pelio

Tasha.pelio@clearlake.com
310-400-8879

For West Monroe

Christina Galoozis

Director, External Communications

cgaloozis@westmonroe.com
847-302-1762

Europe’s CHROs, CIOs and HRIT Leaders Convene to Move Applied AI from Boardroom Priority to Operational Reality

PARIS–(BUSINESS WIRE)– Phenom, the leader in applied AI built to redesign work operations for hiring faster, developing better and retaining longer, today announced the first wave of speakers for IAMPHENOM Europe 2026, the only applied AI event dedicated to human resources taking place on 4-5 November in Paris, France.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260714617871/en/

Phenom today announced the first wave of speakers for IAMPHENOM Europe 2026, the only applied AI event dedicated to human resources taking place on 4-5 November in Paris, France.

At the two-day in-person event, HR professionals, talent acquisition and talent management leaders, HRIT teams and C-suite executives will experience unparalleled immersive AI learning and networking. Attendees will gain actionable strategies from the organisations already using agents and automation to improve work operations and strengthen hiring, development and retention, while connecting with peers navigating the same challenges across Europe.

IAMPHENOM Europe’s first wave of speakers include:

• Lee Barrat, Talent Acquisition Manager at Ageas
• Keir Macintosh, Head of Talent Acquisition at Air Arabia
• Dominik A. Hahn, Global Head of Group Talent Acquisition at Allianz SE
• Kasper Bjerg, Head of Global Talent Acquisition at Arla Foods
• Dr. Hilmar Kroat-Reder, Senior Vice President, People & Culture at Borealis Group
• Cédric Meyer, Group HR Digital Transformation Director at Bouygues Group
• Leonardo Intriago, Group Head of Talent Management & Talent Acquisition at Campari Group
• Lothar Harings, former CHRO at Kuehne+Nagel, Investor
• Mark Crompton, Vice President Talent Attraction at Leonardo
• Yves Bertholomé, Group HRIS-Data & HR People Partners Lead at Proximus
• Liza Follert, Head of Talent Acquisition EMEA at Siemens Healthineers
• Jonathan Berlan, Head of Talent Acquisition and Internal Mobility at UCB

“There’s no single right way to use AI in HR. It depends on the context of your workforce and the infrastructure underneath it,” said Christina Brown, VP & GM, Global Customer Value at Phenom. “The speakers at IAMPHENOM Europe are doing this work inside their organisations every day. Some are further along than others, but every one of them has lessons HR and HRIT teams across Europe need to hear.”

Last Call: Join IAMPHENOM Europe’s Speaker Lineup

Speaking proposals will be accepted until 17 July from HR professionals, talent leaders, industry analysts and technology experts interested in sharing their expertise, inspiring peers and joining a distinguished roster of presenters. Apply at iamphenomeurope.com/speakers.

Register and Learn More

Register before 31 August and save 60% with early bird pricing. Register and learn more at iamphenomeurope.com.

About Phenom

Phenom is an applied AI company with the only AI infrastructure built specifically for HR. Powered by Engines that harmonize data, Ontologies that guide every decision, X AI that hyper-personalizes experiences, and Agents that work alongside teams, Phenom’s platform uses industry and business context to automate workflows, eliminate busywork, and enhance every experience while remaining compliant. Driven by a purpose to help a billion people find the right work, no other company is as dedicated to helping organizations hire faster, develop better and retain longer.

Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (6 consecutive years), Deloitte Technology’s Fast 500 (5 years), 11 Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in Generative AI for Business Impact,’ Business Intelligence Group’s Artificial Intelligence Excellence Awards (3 consecutive years), The Cloud Awards 2025/2024, The A.I. Awards 2024, and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).

Headquartered in Greater Philadelphia, Phenom also has offices in Canada, India, Israel, the Netherlands, Germany and the United Kingdom.

For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, X, Facebook, YouTube, Instagram and TikTok.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260714617871/en/

Contacts

Jennifer Lyons

Phenom

267-379-5066

jennifer.lyons@phenom.com